Results 221 to 230 of about 3,117,738 (383)

Refining Focus in AI for Lung Cancer: Comparing Lesion-Centric and Chest-Region Models with Performance Insights from Internal and External Validation [PDF]

arXiv
Background: AI-based classification models are essential for improving lung cancer diagnosis. However, the relative performance of lesion-level versus chest-region models in internal and external datasets remains unclear. Purpose: This study evaluates the performance of lesion-level and chest-region models for lung cancer classification, comparing ...
arxiv  

Adenocarcinoma of the Bovine Lung Derived from Bronchial Ciliated Epithelial Cells

, 1985
NOBUMI SHIMIZU
openalex   +2 more sources

Association between Smoking and Tumor Progression in Japanese Women with Adenocarcinoma of the Lung [PDF]

, 1999
Ikuo Sekine, Kanji Nagai, Shoichiro Tsugane, Tomoyuki Yokose, Tetsuro Kodama, Yutaka Nishiwaki, Kenji Suzuki, Takayuki Kuriyama   +7 more
openalex   +1 more source

Hepatoid Adenocarcinoma of the Lung [PDF]

C67. THORACIC ONCOLOGY CASE REPORTS I, 2020
R.E. Sell, S. Mahooti, H. Batra-Sharma, D.P. Stefanko   +3 more
openaire   +1 more source

Ribonuclease 1 Induces T‐Cell Dysfunction and Impairs CD8+ T‐Cell Cytotoxicity to Benefit Tumor Growth through Hijacking STAT1

Advanced Science, Volume 12, Issue 13, April 3, 2025.
T‐cell immunotherapy eliminates cancer growth by activating T cells, but immunosuppressive factors hinders their effectiveness, resulting in treatment failure. Here, ribonuclease 1 (RNase1) causes T‐cell dysfunction and promotes exhausted T‐cell signatures in cancers.
Wen‐Hao Yang, Bao‐Yue Huang, Hsing‐Yu Rao, Peng Ye, Bi Chen, Hao‐Ching Wang, Chih‐Hung Chung, Heng‐Hsiung Wu, Hung‐Rong Yen, Shao‐Chun Wang, Jong‐Ho Cha, Xiuwen Yan, Muh‐Hwa Yang, Mien‐Chie Hung   +13 more
wiley   +1 more source

Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma

Molecular Therapy: Oncolytics, 2019
KRAS mutant (KRASmut) lung adenocarcinoma is a refractory cancer without available targeted therapy. The current study explored the possibility to develop coxsackievirus type B3 (CVB3) as an oncolytic agent for the treatment of KRASmut lung ...
Haoyu Deng, Huitao Liu, Tanya de Silva, YuanChao Xue, Yasir Mohamud, Chen Seng Ng, Junyan Qu, Jingchun Zhang, William W.G. Jia, William W. Lockwood, Honglin Luo   +10 more
doaj  

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. [PDF]

BMC Pulm Med, 2021
Ning J, Jiang S, Li X, Wang Y, Deng X, Zhang Z, He L, Wang D, Jiang Y.   +8 more
europepmc   +1 more source

Long-term survival in inoperable adenocarcinoma of the lung.

, 1988
Ryosuke Ono
openalex   +2 more sources

The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma. [PDF]

, 1996
Yona Kalechman, Adi Shani, Sara Dovrat, John K. Whisnant, K.L. Mettinger, Michael Albeck, Benjamin Sredni   +6 more
openalex   +1 more source

Inhalable Hsa‐miR‐30a‐3p Liposomes Attenuate Pulmonary Fibrosis

Advanced Science, EarlyView.
The study explores inhalable hsa‐miR‐30a‐3p‐loaded liposomes as a treatment for bleomycin‐induced pulmonary fibrosis in mice. Hsa‐miR‐30a‐3p is electroporated into liposomes and formulated into a dry powder for inhalation. Delivered via dry powder inhalation, it improves pulmonary function, promotes myofibroblast de‐differentiation by targeting CNPY2 ...
Shuo Liu, Kristen D. Popowski, Christina M. Eckhardt, Weihang Zhang, Junlang Li, Yujia Jing, Dylan Silkstone, Elizabeth Belcher, Megan Cislo, Shiqi Hu, Halle Lutz, Asma Ghodsi, Mengrui Liu, Phuong‐Uyen C. Dinh, Ke Cheng   +14 more
wiley   +1 more source